THE GROUP AT A GLANCE Curanum AG, Munich

CURANUM AG, Munich THE GROUP AT A GLANCE Curanum AG, Munich Overview of key Group figures - Actual as of June 30, 2013 in mill. Q2/2013 Q2/ 2012* H1/2013 H1/2012* 2012 2011* Revenue 72.9 71.7 144.9 142.1 288.8 264.4 Personnel expense 37.4 36.6 74.3 72.4 146.8 134.6 Other expenses 13.1 12.4 27.0 24.9 53.8 49.0 Rental expense 14.0 14.3 28.0 28.5 55.9 53.8 Operating EBITDA 8.4 8.4 15.6 16.3 32.2 27.0 as % of revenue 11.5 11.7 10.8 11.5 11.1 10.2 One-off effects 0.7 0.0 1.5 0.0 0.0 1.8 EBITDA after one-off effects 7.7 8.4 14.1 16.3 32.2 25.2 as % of revenue 10.6 11.7 9.7 11.5 11.1 9.6 Depreciation and amortization 3.4 3.3 6.7 6.6 14.4 11.1 EBIT before impairment charges 4.3 5.1 7.4 9.7 17.8 14.1 Impairment charges 0.0 0.0 0.0 0.0 0.0 22.2 EBIT 4.3 5.1 7.4 9.7 17.8-8.1 as % of revenue 5.9 7.1 5.1 6.8 6.2-3.1 Net financial result -2.7-3.0-5.4-6.1-12.6-11.1 One-off effects 0.6 0.0 0.0 0.0 0.0 0.0 Earnings before tax 2.2 2.1 2.0 3.6 5.2-19.2 Taxes on income 1.0 1.2 0.8 1.7 1.0-6.3 Earnings after tax 1.2 0.9 1.2 1.9 4.2-12.9 Earnings per share (EPS) in 0.03 0.02 0.03 0.05 0.11-0.35 Cash flow from operating activities 6.6 10.1 6.6 10.1 24.0 20.5 CPS in 0.16 0.26 0.16 0.26 0.61 0.56 Net debt 51.1 55.1 51.1 55.1 46.4 50.4 Equity 57.3 48.8 57.3 48.8 55.9 46.8 Equity ratio 21.7 18.4 21.7 18.4 21.3 16.9 Total assets 264.3 265.1 264.3 265.1 262.5 277.6 Employees (as of the balance sheet date; including trainees and staff on maternity/paternity leave) 7,034 7,129 7,034 7,129 7,124 7,078 * Pursuant to IFRS 3.45, adjustments (please refer to the 2012 annual report, Annex A2) and transfers (please refer to the 2012 annual report, Annex C 14) were implemented. 1

CURANUM AG, Munich CONTENTS The Group at a glance.. 1 Group management report on the semi-annual financial statements.. 3 2013 semi-annual financial statements...... 7 Notes to the financial statements... 14 Financial calendar 18 2

CURANUM AG, Munich Group management report on the semi-annual financial statements Macroeconomic trends Overall, forecasts for gross domestic product trends in 2013 assume low growth. By contrast, the care market continued to report slight growth, in line with expectations, being primarily affected by demographic trends and medical progress. The consumer price index was up by 1.8% prospectively compared with the first half of 2012, although general care rates failed to benefit from this to any notable extent. These conditions were reflected in the labor market. Our sector remains characterized by a great lack of specialist staff. Business progress PROFITABILITY The CURANUM Group reported positive operating business trends. Consolidated revenue was up by around 2.0% year-on-year to 145 million. Along with higher inpatient care rates for our facilities, our revenue growth also reflected better utilization of our serviced apartments and outpatient services. Personal expenses grew by 2.6% to around 74 million in the first half of 2013. Costs for temporary help staff and freelancers are now reported entirely within other expenses, rather than in personnel expenditure, as was already the case in the 2012 financial statements. The growth in personal expenditure was due, firstly, to the establishment of centralized structures that was implemented in the second half of 2012. Secondly, it is attributable to wage adjustments at our facilities. By contrast, rental expenses were reduced by 1.8% year-on-year to around 28 million. This was due to the successful closure of rental negotiations for some locations, which offset contractually fixed rental indexations. Other expenses excluding one-off effects were up by 8.4% to 27 million in the first half of 2013. This increase reflects, firstly, the fact that we received a loss compensation payment in 2012 that provided a relief to this expense item. Secondly, it reflects higher energy costs and education fees for our trainees. As a consequence, operating EBITDA (earnings before interest, tax, depreciation and amortization excluding one-off effects) of 15.6 million was around 0.7 million below the previous year's 16.3 million. The Group's structural rationalization was successfully concluded in the first half of 2013 with the merger of 18 subsidiaries. Also, due diligence was conducted for the Phönix Group, and a contribution agreement was concluded that is still subject to approval by the Shareholders' General Meeting. These 3

Curanum AG, Munich projects incurred total extraordinary expenses of 1.5 million. Depreciation and amortization was up by 1.5% to almost 6.7 million, mainly reflecting amortization applied to purchased care documentation software. As a consequence, EBIT, in other words, earnings before interest and tax, amounted to 7.4 million in the first half of the year. These earnings stood at 9.7 million in the previous year. The net financial result for the half-year improved by 11.5% to -5.4 million due to yearon-year lower net debt and lower interest rates. After the expiry of one of the two syndicated loans at the end of the second quarter, a further shareholder loan was entered into with Korian S.A. on similar terms, thereby creating the precondition for the continuation of the interest-rate swap which was entered into in 2008 and which was last adjusted in 2012, as a consequence of which the release which was applied in the first quarter, and which was presented as an one-off effect, was reversed. Corporate income tax expenses fell by 0.8 million, especially due to the taking into account of loss carryforwards connected with the Group's structural rationalization. We reported 1.2 million of earnings after tax in the second quarter as a consequence. NET ASSETS Consolidated net assets were up by 0.7% compared with the start of the year to reach approximately 264 million. On the assets side of the balance sheet, this is mainly attributable to the increase in current assets to around 1.4 million as of June 30, 2013, especially as a consequence of rental prepayments for the month of July. Non-current assets fell slightly by 0.8 million. This is due to depreciation and amortization, as well as a lower level of deferred tax assets, which more than offset the acquisition of a plot of land for our laundry in Kaisersesch. Other non-current assets increased by 1.9 million, by contrast, especially due to the contractually agreed replenishing of cash rental deposits. On the equity and liabilities side of the balance sheet, our interest-bearing liabilities rose by 4.6 million. One of the two banking groups that previously ensured our basic financing decided as of June 30 on the early retirement of the syndicated loan after a waiver process was launched at the end of the first quarter due to non-compliance with financial covenants, and with the banks also being entitled to a special right of cancellation due to an agreed "change of control" clause. This gap was closed by a further shareholder loan granted by Korian S.A. We otherwise assume that the second of the two banking groups will continue to maintain their financing commitment after the agreed covenants were complied with for the second quarter. Trade accounts payable were reduced by 0.9 million. 4

Curanum AG, Munich Equity was up by 2.4% to almost 57.3 million. The equity ratio increased further from 21.3% in the previous year to 21.7% as a consequence. Equity thereby remains above the net debt level. FINANCIAL POSITION The CURANUM Group reports an almost identical cash and cash equivalents position of 16.1 million as of June 30, 2013. This results from a cash inflow from operating activities of 6.6 million, a cash outflow of 4.7 million from investing activities, and a cash outflow of around 1.9 million from financing activities. The cash inflow from operating activities reduced by around 3.5 million year-on-year. This is attributable, firstly, to the reported extraordinary effects of 1.5 million from the Group's structural rationalization and from the preparation for the planned Phönix integration. Secondly, 1.3 million was attributable to rental prepayments for the month of July, and a further 1.3 million relating to contractually agreed rental deposits that required replenishing. We boosted cash inflow from operating activities by 0.6 million when adjusted to reflect these three reported extraordinary items. The cash outflow from investing activities amounted to 4.7 million, down 3.4 million year-on-year. While 4.9 million was attributable in the previous year to the acquisition of the GWA Group, investments and existing facilities increased by 1.5 million to 4.7 million. This amount also contains the purchase of a plot of land for our existing laundry in Kaisersesch. The cash outflow of 1.9 million from financing activities primarily reflects the topping up of interest-liabilities and a scheduled decline in lease liabilities. Employees With 7,034 Group staff as of the reporting date, the number of employees stood almost at the previous year's level (previous year: 7,129). The CURANUM Group employed 401 trainees as of the first-half reporting date. This is 106 more than in the prior-year period. The share The share price in the first half of the year rose from 2.50 on January 1 to 2.72 on June 30, representing an 8.8% increase. Average daily trading turnover amounted to 76,535 shares in electronic trading (Xetra) in the first half of the year. Risks and opportunities attached to business development Compared with the presentation made in our report on the 2012 financial year, no notable changes occurred to the risks and opportuni- 5

Curanum AG, Munich ties pertaining to our business development. Given the planned integration of the Phönix Group into our company, negotiations with the banking group that finances us have not yet been concluded. Financing risk continues to exist to this extent. We nevertheless assume that this will no longer be the case once the syndicated loan has been re-concluded. Alternatively we would enter negotiations with Korian S.A. regarding a follow-up financing. expect not only significant additional growth impulses for next year, but also a sustainable improvement in operating earnings, as well as a more stable equity ratio. Munich, July 18, 2013 Curanum AG The Management Board Two of our facilities were affected by last month's storms. This created significant damage. We are confident, however, that such damage is largely covered by insurance policies in place. Outlook Walther Wever (CEO) Patricia Emmel (CFO) We are assuming that the positive trend in the care sector will continue, and expect a further improvement in revenue and operating earnings by the year-end in our existing business because of the launched entrepreneurial measures. We have signed a sales agreement with effect as of August 31, 2013 for one location that lies outside of our clusters. We do not expect this to generate any negative earnings effects, however. Finally, we are planning some earnings effects as a consequence of the integration of the Phönix Group that we aim to implement as of September 1. Although we initially anticipate some short-term extraordinary charges and preliminary investments, we otherwise 6

Curanum AG, Munich Consolidated balance sheet as of June 30, 2013 Assets in T Jun 30, 2013 Dec 31, 2012 Current assets Cash and cash equivalents 16,136 16,207 Trade receivables 9,378 8,392 Inventories 1,207 1,207 Other assets 4,457 3,053 Income tax receivables 370 112 Total current assets 31,548 28,971 Non-current assets Property, plant and equipment 147,734 149,450 Other intangible assets 4,398 4,681 Goodwill 57,644 57,644 Deferred tax 17,116 17,862 Other assets 5,815 3,892 Total non-current assets 232,707 233,529 Total assets 264,255 262,500 7

Curanum AG, Munich Equity and liabilities in T Jun 30, 2013 Dec 31, 2012 Current liabilities Lease liabilities 6,592 6,538 Financial liabilities 25,834 10,659 Trade payables 5,863 6,782 Provisions 896 768 Income tax liabilities 1,227 1,421 Liabilities to shareholders 1,034 0 Other liabilities 19,390 19,330 Total current liabilities 60,836 45,498 Non-current liabilities Lease liabilities 97,449 100,740 Financial liabilities 31,356 51,955 Deferred tax 4,927 4,898 Liabilities to shareholders 9,000 0 Provisions 3,430 3,509 Total non-current liabilities 146,162 161,102 Equity Share capital 42,507 42,507 Additional paid-in capital 39,003 39,003 Treasury shares -1,241-1,241 Revenue reserve and profit/loss carried forward -23,629-27,763 Consolidated net income 1,202 4,163 Other comprehensive income -585-822 Non-controlling interests 0 53 Total equity 57,257 55,900 Total equity and liabilities 264,255 262,500 8

Curanum AG, Munich Consolidated income statement for the period from January 1, 2013 until June 30, 2013 in T Q2/2013 Q2/2012 H1/2013 H1/2012 1. Revenue* 72,947 71,656 144,933 142,089 2. Cost of sales 61,126 61,827 124,358 123,970 3. Gross profit 11,821 9,829 20,575 18,119 4. Selling and marketing expenses 484 335 838 633 5. General administration expenses 7,418 6,178 13,954 11,598 6. Other operating expenses 256 143 1,098 434 7. Other operating income* 648 1,925 2,733 4,234 8. Operating profit 4,311 5,098 7,418 9,688 9. Interest and similar expenses 2,236 3,041 5,613 6,139 10. Other interest and similar income 151 25 219 51 11. Earnings before income taxes 2,226 2,082 2,024 3,600 12. Taxes on income 992 1,209 822 1,673 13. Earnings after income taxes 1,234 873 1,202 1,927 of which earnings attributable to non-controlling interests 0 0 0 6 of which earnings attributable to Curanum AG shareholders 1,234 873 1,202 1,921 Basic and deluted earnings per share on basis of earnings attributable to bearers of Curanum AG ordinary shares 0.03 0.02 0.03 0.05 Number of outstanding shares taken as basis 40,851,980 38,799,835 40,851,980 38,799,835 * In the previous financial year, reimbursements unconnected with the operating business were reclassified to other operating income. 9

Curanum AG, Munich Statement of consolidated comprehensive income for the period from January 1, 2013 until June 30, 2013 in T Q2/2013 Q2/2012 H1/2013 H1/2012 Earnings after income taxes 1,234 873 1,202 1,927 Items which will potentially be relocated to gains or losses Gains/losses from change in fair value of financial instruments deployed for hedging purposes -393 20 357 32 Deferred tax relating to earnings-neutral components of comprehensive income for the period 119-5 -108-9 Items which will not be relocated to gains and losses Losses from other changes carried directly to equity -7 0-12 0 Total value changes reported in equity 281 15 237 23 Total of after-tax earnings and value changes reported in equity 953 888 1,439 1,950 of which attributable to non-controlling interests 0 0 0 6 of which attributable to Curanum AG shareholders 953 888 1,439 1,944 10

Curanum AG, Munich Consolidated statement of changes in equity for the period from January 1, 2013 until June 30, 2013 Revenue reserve All amounts in T Share capital Capital reserves Accumulated profit/loss Other revenue reserves Actuarial gains/losses Dec 31, 2011* 39,192 37,460-28,224 822 94 Total of after-tax earnings and value changes reported in equity 0 0 1,921 0 0 Miscellaneous changes 0 0 0-77 0 Jun 30, 2012 39,192 37,460-26,303 745 94 Dec 31, 2012 42,507 39,003-24,061 741-280 Total of after-tax earnings and value changes reported in equity 0 0 1,202 0 0 Purchase of non-controlling interests 0 0 0 27 0 Miscellaneous changes 0 0 0-56 0 Jun 30, 2013 42,507 39,003-22,859 712-280 *The previous year's figures have been adjusted pursuant to IFRS 3.45. 11

Curanum AG, Munich Other comprehensive income Equity attributable to Curanum AG shareholders Non-controlling interests Equity Repurchase of treasury shares Revaluation reserve Cash flow hedge Total Total Total -1,241 486-1,691 46,898 39 46,937 0-9 32 1,944 6 1,950 0 0 0-77 0-77 -1,241 477-1,659 48,765 45 48,810-1,241 469-1,291 55,847 53 55,900 0-12 249 1,438 0 1,438 0 0 0 27-53 -26 0 0 0-56 0-56 -1,241 457-1,042 57,257 0 57,257 12

Curanum AG, MUNICH Consolidated cash flow statement for the 2013 financial year of Curanum AG, Munich in T Jun 30, 2013 Jun 30, 2012 I. Operating activities Earnings before taxes and minority interests 2,024 3,600 Depreciation/amortization and impairments of non-current assets 6,690 6,615 Other interest and similar income -219-51 Interest and similar expenses 5,613 6,139 Gains from the disposal of assets 44 56 Other non-cash expenses/income -324 0 Change in working capital -5,142-3,967 Income taxes paid -300-229 Income taxes received 33 109 Interest paid -1,936-2,167 Interest received 115 35 Cash flow from operating activities 6,600 10,140 II. Investing activities Cash inflows from corporate acquisitions 0-4,856 Cash outflows for investments in property, plant and equipment, and intangible assets -4,735-3,248 Cash outflow from investing activities -4,735-8,104 III. Financing activities Cash outflows for redemption of financial liabilities -6,918-3,754 Cash inflows from drawing down of financial liabilities 11,750 0 Cash outflows for finance leasing (interest and redemption components) -6,768-6,697 Cash outflow from financing activities -1,936-10,450 Net change in cash and cash equivalents -71-8,414 Cash and cash equivalents at the start of the period 16,207 21,192 Cash and cash equivalents at the end of the period 16,136 12,778 13

Curanum AG, MUNICH NOTES TO THE FINANCIAL STATEMENTS 1. General information on the company Curanum Aktiengesellschaft (referred to below as "Curanum AG" or the "company") is headquartered at Engelbertstrasse 23-25, 81241 Munich, Germany. The business objective of Curanum AG and its subsidiaries is the creation and operation of senior citizen and residential care homes. Curanum AG, as the ultimate parent company of the CURANUM Group, has prepared this set of consolidated financial statements. Basis of preparation These unaudited semi-annual financial statements have been prepared according to International Financial Reporting Standards (IFRS). As of the time of transfer to IFRS on January 1, 2004, Curanum AG prepared a set of opening accounts that provide the starting point for IFRS accounting. 2. Accounting principles With the exception of the special circumstances detailed below, the accounting and valuation principles comprise no significant changes compared to those used for reporting purposes as of December 31, 2012. Please refer to the related notes in the consolidated financial statements as of December 31, 2012. Statement of compliance with IFRS The half-year financial statements of Curanum AG and its subsidiaries were prepared in accordance with International Financial Reporting Standards (IFRS) as approved by the European Union. The income statement has been prepared according to the cost of sales method. These half-year financial statements have been prepared in harmony with IAS 34, and do not necessarily contain all information presented in the consolidated financial statements. Reference should be made to the consolidated financial statements as of December 31, 2012, which were prepared according to IFRS. The half-year financial statements are prepared in euros. All values have been rounded to the nearest thousand euros (T ) unless otherwise stated. The tables and notes may contain rounding differences compared with the precisely mathematically calculated figures. 14

Curanum AG, MUNICH SCOPE OF CONSOLIDATION Name Registered office Interest held % 1) The following German companies were fully consolidated as of June 30, 2013 (in alphabetical order): 1 Altenheim Betriebsgesellschaft West GmbH Munich 100.0 2 Bad Schwartauer AVG Altenheim-Vermietung GmbH & Co. KG 2) Munich 100.0 3 CURANUM AG (parent company) Munich -- 4 CURANUM Akademie Stiftung gemeinnützige GmbH Munich 100.0 5 CURANUM Betriebs GmbH 7) Munich 100.0 6 CURANUM Betriebs GmbH Mitte (formerly: Residenzen Niederrhein GmbH) 4) Munich 100.0 7 CURANUM Betriebs GmbH West (formerly: VGB Beteiligungs- und Verwaltungs- GmbH) 5) Munich 100.0 8 CURANUM Dienstleistung GmbH Munich 100.0 9 CURANUM Franziskushaus GmbH Gelsenkirchen 100.0 10 CURANUM Holding GmbH Munich 100.0 11 CURANUM Liesborn GmbH & Co. KG 2) Munich 100.0 12 CURANUM Verwaltungs- und Beteiligungs GmbH & Co. KG Munich 100.0 13 doc Orange GmbH 6) Munich 100.0 14 GAP Media Service GmbH Munich 100.0 15 RIAG Seniorenzentrum "Ennepetal" GmbH & Co. KG 2) Munich 100.0 16 RIAG Seniorenzentrum "Erste" GmbH & Co. KG Munich 100.0 17 RIAG Seniorenzentrum Zweite GmbH & Co. KG Munich 100.0 18 Service Gesellschaft West GmbH Munich 100.0 1) 2) 3) 4) 5) 6) 7) The interest held corresponds to the voting rights. Curanum AG acquired all minority interests in the first quarter of 2013. The difference between the purchase cost and the shares' carrying amount was offset directly with the revenue reserves (please also refer to the consolidated statement of changes in equity). The spin-off of the shares held by Curanum Holding GmbH in OPTICURA Service GmbH, Wäscherei Ellerich GmbH and Lucullus GmbH to CURANUM Baubetreuung und Immobilienmanagement GmbH occurred with retrospective effect as of January 1, 2013 (commercial register entry: January 31, 2013). On February 4, 2013, the spin-off of the shares in CURANUM Baubetreuung und Immobilienmanagement GmbH of CURANUM Verwaltungs- und Beteiligungs GmbH & Co. KG to CURANUM Erste Service GmbH & Co. KG, which was newly founded in the 2013 financial year, was likewise entered in the commercial register (commercial register entry January 18, 2013). On February 12, 2013, with the entry in the commercial register, the companies Lucullus GmbH and Wäscherei Ellerich GmbH were merged with CURANUM Baubetreuung und Immobilienmanagement GmbH with retroactive effect as of January 1, 2013. Subsequently with effect as of January 1, 2013, the two companies OPTICURA Service GmbH and CURANUM Baubetreuung und Immobilienmanagement GmbH were merged with CURANUM Erste Service GmbH & Co. KG (mergers entered in the commercial register on February 18, 2013). On February 18, 2013, with the entry in the commercial register, the accrual of CURANUM Erste Service GmbH & Co. KG to Curanum AG became effective with retroactive effect as of January 1, 2013. This company changed its corporate name; this change was entered in the commercial register on February 14, 2013. With retroactive effect as of January 1, 2013, the companies Alten- und Pflegeheim Sieglar GmbH (commercial register entry March 4, 2013), Krankenheim Ruhesitz am Wannsee-Seniorenheimstatt GmbH (commercial register entry January 28, 2013) and Seniorenzentrum Hennef GmbH (commercial register entry February 18, 2013) were merged with CURANUM Betriebs GmbH Mitte (formerly: Residenzen Niederrhein GmbH). This company changed its corporate name; this change was entered in the commercial register on February 14, 2013. On February 18, 2013, with the entries in the commercial register, the mergers of ELISA Seniorenstift GmbH and FAZIT Betriebsträgergesellschaft für soziale Einrichtungen mbh with CURANUM Betriebs GmbH West (formerly: VGB Beteiligungs- und Verwaltungs-GmbH) became effective with retroactive effect as of January 1, 2013. This company was founded on March 28, 2012, and was entered in the commercial register on April 18, 2012. With retroactive effect as of January 1, 2013, the companies Altenheim Betriebsgesellschaft Ost GmbH, Altenheim Betriebsgesellschaft Süd GmbH, CURANUM Bad Hersfeld GmbH, CURANUM Bessenbach GmbH, CURANUM Westfalen GmbH, Wohnstift Bremen GmbH (formerly: Bremer Wohnstift gemeinnützige GmbH), Wohnstift Lingen GmbH (formerly: Wohnstift Lingen gemeinnützige GmbH), Wohnstift Salzgitter-Bad GmbH (formerly: Wohnstift Salzgitter-Bad gemeinnützige GmbH) and Wohnstift Timmendorf GmbH (formerly: Timmendorfer Wohnstift gemeinnützige GmbH) were merged with CURANUM Betriebs GmbH (commercial register entry May 6, 2013). 15

Curanum AG, MUNICH Accruals, spin-offs and mergers Pursuant to IFRS 3.2c, the aforementioned intra-group transactions, which comprise the merger of companies under joint control, do not fall into the application scope of IFRS 3 "Business Combinations". At Group level, these transactions were accounted for on the basis of the entity theory, as a consequence of which the carrying amounts were carried forward. The respective separate financial statements' transaction bookings consequently had no effect on the semi-annual financial statements. Events after the balance sheet date (IAS 10.21) On July 4, 2013, the Supervisory Board approved the contribution of the shares of Phönix Seniorenzentren Beteiligungsgesellschaft mbh. The contribution agreement was then officially recorded by a notary on July 6, 2013. The contribution of the shares is subject to the condition precedent that the Shareholders' General Meeting of Curanum AG passes a corresponding resolution concerning an increase of capital. Otherwise, please refer to our ad hoc announcement from July 4, 2013. Earnings per share Please refer to the note to the income statement in these semi-annual financial statements concerning earnings per share. Related parties Please refer to the notes to the consolidated financial statements as of December 31, 2012, concerning related parties disclosures. One significant change has occurred compared with the consolidated financial statements as of December 31, 2012. Korian Deutschland AG, Mannheim, Germany, announced in the Federal Gazette on March 26, 2013 that, following the expiry of the takeover offer's further acceptance period pursuant to Section 16 (2) Clause 1 of the German Securities Takeover Act (WpÜG), it owns a direct majority participating interest of 78.45% in Curanum AG. Korian S.A. Paris, France, directly holds a 100% interest in Korian Deutschland AG, Germany. As a consequence, Korian S.A. holds an indirect interest of 78.45% in Curanum AG through Korian Deutschland AG. On March 13, 2013, Korian S.A. informed us pursuant to Section 21 (1) of the German Securities Trading Act (WpHG) that the voting rights share of Korian S.A. had exceeded the 75% threshold and amounted to 78.40% as of this date. Korian S.A. is listed on NYSE Euronext Paris in the Compartement B (ISIN: FR0010386334). From March 2013, Korian S.A., as the parent company of the larger scope of consolidation, includes Curanum AG in its consolidated financial statements by way of full consolidation. Two loans totaling T 10,000 exist with Korian S.A. as of June 30, 2013. While one loan carries fixed interest, we have agreed variable interest payments for the other, in order to also continue with our existing swap without incurring charges to earnings. Both loans are reported in the balance sheet under the item liabilities to shareholders. A total with a residual term of less than one year amounts to T 1,034 (including T 34 of deferred interest as of June 30, 2013). 3. Segment reporting The CURANUM Group renders all services for an identical group of customers, and operates exclusively on the German market. These services' opportunity and risk profiles are not significantly different, and are interdependent. For this reason, the business segments that have been identified are summarized in line with the provisions of IFRS 8. Since no separate reporting segments exist in the meaning of IFRS 8, no presentation by business divisions has been made. 4. Contingent liabilities and claims Contingent liabilities were not recognized in the halfyear financial statements. They are disclosed in the notes to the consolidated financial statements except where a possibility of an outflow of resources embodying economic benefits is highly unlikely. 5. Non-current and current financial liabilities As a consequence of the majority takeover of our company by Korian Deutschland AG, the banks that provide us with financing enjoy a special right of cancellation due to the agreed change of control clauses. We have also launched a waiver process that is not yet fully concluded. As a consequence, such loans are reported as 16

Curanum AG, MUNICH current financial liabilities as of June 30, 2013, pursuant to IAS 1.74. We are assuming that the banks will not utilize their special cancellation rights, with the exception of one banking group that has already announced that it will no longer provide financing in the future. Korian S.A. has provided a corresponding Group financing; please refer to Notes 2, in the section on "Related Parties". 6. Executive bodies of Curanum AG Mrs. Patricia Emmel was appointed as the new Chief Financial Officer as of May 1, 2013. 7. Responsibility statement To the best of our knowledge, and in accordance with the applicable reporting principles for interim financial reporting, the interim consolidated financial statements give a true and fair view of the assets, liabilities, financial position, and profit or loss of the Group, and the interim Group management report includes a fair review of the development and performance of the business and the position of the Group, together with the description of the principal opportunities and risks associated with the expected development of the Group in the remainder of the financial year. Munich, July 18, 2013 Curanum AG The Management Board Walther Wever (CEO) Patricia Emmel (CFO) 17

Curanum AG, MUNICH FINANCIAL CALENDAR August 21, 2013 November 6, 2013 Ordinary Shareholders' General Meeting in Munich Q3/2013 report 18